Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (4): 244-247.
Previous Articles Next Articles
FANG Yan-xue, MA Dan*
Received:
2018-05-29
Revised:
2018-05-29
Online:
2018-04-20
Published:
2018-05-29
CLC Number:
FANG Yan-xue, MA Dan. Analysis of 45 Cases of Adverse Drug Reactions Induced by Lamiophhmis Rotata (Benth.) Kudo Preparations[J]. Chinese Journal of Pharmacovigilance, 2018, 15(4): 244-247.
[1] 曾阳, 陈学军, 陈振宁. 藏药独一味的研究进展[J]. 中草药, 2001, 32(12): 1141-1143. [2] 孙辉, 蒋舜媛, 冯成强, 等. 独一味Lamiophhmis rotate 野生资源现状与存在的问题[J]. 中国中药杂志, 2012, 37(22): 3500-3505. [3] 昝珂, 焦兴苹, 过立农, 等. 藏药独一味及其伪品HPLC特征图谱和4种成分含量测定[J]. 中国中药杂志, 2016, 41(12): 2284-2290. [4] 李茂星, 贾正平, 张汝学. 镇痛止血药独一味的研究概况[J]. 中药材, 2004, 27(3): 222-224. [5] 关枫, 王艳宏. 藏药独一味药理作用及临床应用新进展[J]. 世界科学技术-中医药现代化, 2007, 9(2): 104-106, 110. [6] 张涛, 张汝学, 贾正平. 藏药独一味的制剂研究进展[J]. 甘肃医药, 2014, 33(12): 908-911. [7] 孟保华, 孟宪丽. 藏药独一味药理作用研究进展[J]. 中国药房, 2009, 20(3): 232-233. [8] 曾令军, 林兵, 宋洪涛. 中药谱效关系研究进展及关键问题探讨[J]. 中国中药杂志, 2015, 40(8): 1425-1432. [9] 王丽娟, 彭 , 王勇, 等. 独一味对实验性小鼠胃溃疡的影响[J]. 时珍国医国药, 2009, 20(5): 1189-1190. [10] 龚磊. 藏药独一味治疗带状疱30例[J].临床皮肤科杂志, 2001, 30(2):95-95. [11] 龚立军, 张娟红, 杜华, 等.独一味胶囊对带状疱疹患者的镇痛作用[J].西南军医, 2014, 16(5):515-516. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||